Whether youre dealing with joint degeneration, soft tissue damage, or spinal inflammation, our regenerative approach offers real, lasting results without shortcuts
Summary Keywords diabetes mellitus, pulmonary injury, metabolic dysregulation, gut-lung axis, intestinal dysbiosis Citation Sun J, Chen J, Shen Y, Yao X, Sun H, Chen B and Feng J (2025) Diabetes mellitus-driven pulmonary injury: multidimensional mechanisms linking metabolic dysregulation to gut-lung axis and promising therapies
SR-J1 (RAGE) is an SR expressed on endothelial cells that plays a role in triggering NETosis (279) and, together with clathrin, mediates the uptake of NETs
(PubMed) That doesnt automatically translate to healthier, and it certainly doesnt translate to safe to combine with other secretagogues indefinitely. A clinician-friendly framework to evaluate any peptide stack you see online If you want the full decision logic, use Metos pillar: Heres the condensed version Id use in a consult: Step 1: Define the outcome in one sentence Not fat loss. Instead: Reduce visceral adiposity and improve triglycerides in 12 weeks, or Improve return-to-running tolerance after a tendon injury. Step 2: Grade evidence, not enthusiasm Use three buckets: A: Human outcomes evidence (best) B: Human biomarker evidence (useful but indirect) C: Preclinical/mechanistic only (hypothesis) Example: Semaglutide for weight loss: A CJC-1295 for raising IGF-1: B BPC-157/TB-500 for tendon healing: often C low B , depending on claim Step 3: Avoid redundancy If two compounds push the same pathway, youre more likely to get side effects than synergy
